Nanologica AB (NICA.ST) - Halal (Shariah-Compliant)
Nanologica AB (NICA.ST) is classified as Halal (Shariah-Compliant) according to AAOIFI Shariah screening standards. This assessment is based on business activity screening and financial ratio analysis using the AAOIFI methodology.
Business Activity Screen
- Sector
- Healthcare
- Industry
- Biotechnology
- Result
- Pass
- Reason
- The sector "Healthcare" and industry "Biotechnology" are not in the excluded categories.
Financial Ratios
- Debt Ratio
- Value: 20.9% | Threshold: 30% | Result: Pass
- Cash & Interest-bearing Securities Ratio
- Value: 7.4% | Threshold: 30% | Result: Pass
- Non-Permissible Income Ratio
- Value: 0.9% | Threshold: 5% | Result: Pass
Dividend Purification
Purification percentage: 0.93%.Based on the company's financial statements, approximately 0.93% of dividend income comes from non-permissible sources; this is the share many investors donate to purify it. This is derived from identified interest income (0.93% of total income). Some scholars may differ on the exact calculation method.
About Nanologica AB
Nanologica AB (publ), a life science tools company, develops, manufactures, and sells nanoporous silica particles in China, India, Turkey, the United States, and internationally. The company offers NLAB Saga, a silica-based purification media for preparative chromatography that is developed for the purification of peptide drugs, such as insulin and GLP-1 analogues; NLAB Idun, an ion exchange product for robust, reproducible, and efficient downstream purification of GLP-1 analogues and other peptides; NLAB Idun SP, a strong cation exchanger with sulfopropyl groups as ligands; NLAB Idun Q, a strong anion exchanger with a quaternary amine ligand; and NLAB Siv, a non-silica-based media for purification by preparative chromatography used for products outside the peptide range. It also provides high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces; and analytical chromatography, an analysis method in the pharmaceutical and food industries. The company's products are used to purify substances with a focus on peptide drugs for the treatment of diabetes and obesity. It serves pharmaceutical companies, as well as contract manufactures of insulin and insulin analogues, GLP-1 analogues, biosimilars to insulin and GLP-1 analogues, and other peptide drugs. Nanologica AB (publ) was incorporated in 2004 and is headquartered in Södertälje, Sweden.
